Tech Company Financing Transactions
Midway Pharmaceuticals Funding Round
Midway Pharmaceuticals closed a $300 thousand investment round on 4/28/2017. Investors included private investors.
Transaction Overview
Company Name
Announced On
4/28/2017
Transaction Type
Debt
Amount
$300,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. 5 investors participated in the offering. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
2 Pump House Dr.
Spring House, PA 19477
USA
Spring House, PA 19477
USA
Phone
Website
Email Address
Overview
Midway Pharmaceuticals is a development-stage biopharmaceutical company based in Spring House, PA. This technology platform is expected to generate future innovative cytoprotective and anti-inflammatory GI drugs.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Rifat Pamukcu
Browse more venture capital transactions:
Prev: 4/28/2017: ArunA Biomedical venture capital transaction
Next: 4/28/2017: Clark venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to report on every notable VC transaction. VC transactions on this site are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs